Minnesota SF 366: Diabetes prescription drugs cost reporting requirement

Status: Referred to Health and Human Services Finance and Policy (as of 2019-01-22)

State: Minnesota · Session: 2019-2020 · Bill: SF 366

Subjects: Drugs and Medicine

Sponsors: Little, Abeler, Carlson, Torres Ray, Wiklund

View Minnesota SF 366 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.